Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

1.98 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -46.495-99.038-7.585-12.078-105.959-6.462-11.943-1.34887.42999.653156.721146.86126.244132.81134.34475.85214.47239.0231.44223.879-5.45
Depreciation & Amortization 14.52614.79314.54713.75312.9813.09611.79810.90710.0299.90910.7837.3823.4447.0767.3386.8945.9256.6716.4756.7666.635
Deferred Income Tax 2.3170.31100764.75-5.532-2.756-1.527.0119.23412.85613.21717.46611.2276.45111.76-4.189-0.0010-1.274-1.159
Stock Based Compensation 10.54513.0513.76312.0579.3429.9879.2725.9875.9954.744.3083.6272.233.5672.3832.27821.6961.8490.5760.5080.516
Change In Working Capital -10.0148.4632.242-10.6412.3798.57218.55268.341-15.761-9.955-11.128-8.238-104.315-34.35714.896-52.85535.5673.141.915-4.7298.394
Accounts Receivables -11.3459.842-2.02117.883-8.7853.2127.56182.407-25.7745.834-0.115-2.217-51.5417.6234.341-70.81222.276-45.6780.344-10.0860.695
Change In Inventory 0.32700.7510.82-2.184-1.4957.711-3.38319.273-2.312-8.7031.2014.689-8.19-4.245-13.828-6.715-4.461-2.558-5.3651.057
Change In Accounts Payables 2.25404.571-3.6821.6591.9861.874-0.235-3.468-4.424.361.95-0.867-2.5422.1881.8971.046-3.2890.0173.4021.559
Other Working Capital -1.25-1.379-1.059-25.66211.6894.8691.406-10.448-5.792-9.057-6.67-9.172-56.597-41.245-17.38829.88818.9656.5684.1127.325.083
Other Non Cash Items 14.48375.557-5.53312.984-675.702-5.495-5.7292.7074.632-3.522-9.261-0.54413.098-14.4670.42-5.2145.960.7461.207-15.4370.309
Operating Cash Flow -14.63813.13617.434-8.4677.7914.16619.19485.07499.335110.059164.279162.30458.167105.856165.83238.71579.43151.42811.6159.7139.245
Investing Activities:
Investments In Property Plant And Equipment -5.849-8.591-9.553-5.665-16.799-15.827-25.059-7.868-6.214-6.467-1.661-2.748-5.662-1.406-4.202-3.58-8.849-10.091-3.059-3.409-4.76
Acquisitions Net 000074.91100.109-69.731-0.1330.620-238.8360119.95700.548-3.02400-3.0240
Purchases Of Investments 000000000000000000000
Sales Maturities Of Investments 000000000000000000000
Other Investing Activites 0.918-0.3683.3711.4213.8960.3070.7937.869-12.1730.62000119.95700.5483.0240031.4760
Investing Cash Flow -4.931-8.959-6.182-4.244-12.903-15.52-24.157-69.73-18.52-5.847-1.661-241.584-5.662118.551-4.202-3.032-8.849-10.091-3.05928.067-4.76
Financing Activities:
Debt Repayment -229.54-1.52-1.508-1.5050-1.484-1.426-1.36-1.36-1.36-1.36-1.36-0.918-1.717-1.724-1.641183.822-0.571-0.66614.339-0.656
Common Stock Issued 000-1.433-0.0200-0.3330.3650.730.5370.7260.380.3110.4480.571,757.2450000
Common Stock Repurchased 0-0.019-0.028-1.433-0.35100-0.33300000000-42.7980000
Dividends Paid 000000000000000000000
Other Financing Activities -6.6492.3291.7360.9450.8212.267-41.708-17.516-64.763-36.082-42.051-39.163-48.46-49.567-32.403-22.558-143.15-0.372-0.1900.7
Financing Cash Flow -236.1890.8090.228-0.560.470.783-43.134-19.209-66.123-37.442-43.411-40.523-48.998-51.501-34.351-24.19940.672-0.943-0.85614.3390.044
Other Information:
Effect Of Forex Changes On Cash 000000000000-0.1330.0320.0060.0070.0480.030.011-0.0720.055
Net Change In Cash -255.7584.98611.48-13.271-4.643-0.571-48.097-3.86514.69266.77119.207-119.8033.374173.188127.03511.491111.30240.4247.71152.0474.584
Cash At End Of Period 322.399578.157573.171561.691574.962579.605580.176628.273632.138617.446550.676431.469551.272547.898374.71247.675236.184124.88284.45876.74724.7